The mechanisms by which hematopoietic progenitor Cells become lineage-commi ¶ted remain poorly understood. A cloned subline of the AML14 cell line (AMLl4.3D10) that Spontaneously differentiates to eosinophilic myelocytes in the absence of cytokine stimulation was obtained by limiting dilution. This subline exhibits augmented expression of interleukin-5 (IL-5) receptor a subunit mRNA and synthesizes all major eosinophil granule proteins. Exposure of this cell line to all-trans retlnoic acid (ATRA) causes loss of eosinophilic granules and fast green staining within 48 hours, without cell death. In addition, mRNA for the IL-5 receptor a subunit becomes undetectable by 48 hours and the cells lose responsiveness to IL-5. Major basic protein, measured as a marker of eosinophilic granule content, decreases from more than 16 pg/cell to undetectable levels by 5 days after ATRA. Concomitant with the loss of major basic protein and EMATOPOIESIS is initiated by stem cells that are pluripotent for all hematopoietic lineages. These stem cells are capable of self-renewal and also produce progeny that, according to two prevalent models, either commit to a single lineage by a stochastic process or become increasingly lineage-restricted through successive generations until commitment is ultimately made to a single cell lineage.' In either model, once differentiation along a lineage becomes evident by the production of lineage-specific proteins, it has been assumed that lineage commitment is irreversible, although cell division may still be possible. ' The AML14 leukemic cell line, which is blast-like but differentiates to eosinophils after stimulation with eosinophil-active cytokines? has shown its utility as a model for the study of the regulation of the growth and differentiation of eosinophil^.^,^ A stable cloned subline of AML14 (AML14.3D10) has been established that spontaneously differentiates to eosinophils in the absence of cytokine stimulation. We show that exposure of this cell line to all-trans retinoic acid (ATRA) results in suppression of the eosinophil differentiation program and activation of the neutrophil differentiation program. This does not occur solely by induction of an alternative lineage selection in as yet uncommitted cells, but rather results at least partially from a shift in the differentiation program of cells that already show advanced stages of eosinophilic differentiation. These findings suggest that lineage commitment may not be final and establish a model for the study of transcriptional regulation underlying lineage selection.
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MATERIALS AND METHODS
Establishment of the AML14.3DIO Eosinophilic Subline
The establishment and properties of the eosinophil-inducible parental AML14 leukemic cell line have been previously de~cribed.~.' After serial passages in culture with supplementation by interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-5, a subline was observed to emerge in one flask that did not require cytokine supplementation for eosinophilic differentiation. Cells in this flask spontaneously differentiated to at least the eosinophilic myelocyte stage and retained vigorous proliferative analysis of differentiation related antigens, and other studies, as Nonvalk, CT), following the manufacturer's instructions. Optimal described below.
primers and annealing conditions were computer selected using the Oligo program (National Biosciences, Plymouth, MN). To control
Assessment of Lineage-SpeciJic Gene Expression
for augmented signals caused by contaminating genomic DNA, the Semiquantitative reverse transcriptase-polymerase chain reaction following precautions were taken. Primers selected for RT-PCR of (RT-PCR). Total cellular RNA was isolated from cells using stanmRNA for major basic protein (MBP), eosinophil peroxidase @PO), dard methodology as previously described.' The RT-PCR was perand Charcot-Leyden crystal protein (CLC) were chosen to frame formed using the GeneAmp RNA PCR kit (Perkin Elmer Cetus, sequences that cross introns, based on the published genomic DNA sequences for these genes?' The primers used for amplification of granulocyte colony-stimulating factor (G-CSF)-receptor mRNA also span introns? For studies of eosinophil-derived neurotoxin (EDN) and the IL-S receptor ( I subunit (IL-S Re), duplicate amplifications were performed, including all primers and reagents but omitting reverse transcriptase. Amplified products were assumed to be derived from RNA, rather than contaminating DNA, if no amplified product was detected in the duplicate reactions from which reverse transcriptase was omitted. Glyceraldehyde-3-phosphate dehydrogenase were added. The tubes were mixed and incubated at 4°C for 3 hours
-----Days
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For personal use only. on October 3, 2017. by guest www.bloodjournal.org From 3740 and then centrifuged at 1,500g for 20 minutes at 4°C. Supernatants were decanted and radioactivity in the precipitates was measured by y scintillation counting. The concentration of MBP in AML14.3D10 cells was determined by comparison to a reference curve constructed from the analysis of known quantities of the purified reduced and alkylated MBP standards, as previously described."."
Flow cytometric analysis of differentiation-related anitgens. At sequential timepoints, aliquots of AML14.3D10 cells cultured with and without ATRA were washed twice and suspended at a concentration of 1 X lo6 cells/mL in 100 pL PBS. One sample from each group was then incubated for 10 minutes at 4°C with a previously determined optimal concentration of fluorescein isothiocyanate (F1TC)-conjugated monoclonal antibody (MoAb) to CD33 (MY9; Coulter Immunology, Hialeah, FL) or CD16 (Leu1 IC; Becton Dickinson, Mountain View, CA). The samples were then washed twice in PBS and analyzed on a Becton Dickinson FACScan flow cytometer. Fluorescence intensity resulting from bound antibody was compared with that of samples incubated with FITC-conjugated isotypematched MoAb with no human tissue specificity as the negative standard.
Production of Cytokine mRNA by AML14.3DIO Cells
To screen AML14.3D10 cells for production of cytokines active on eosinophils or neutrophils, RT-PCR was performed on RNA isolated from cells before and 10 days after ATRA induction. Oligonucleotide primers for the detection of mRNA for IL-3, GM-CSF, IL-5 and G-CSF were obtained from Clontech Laboratories, Inc. All primer sets were known to span introns based on published genomic sequences.13"6 Conditions for reverse transcription and amplification were as described above.
Nitroblue Tetrazolium (NBT) Reduction
NBT reduction was assayed as described." Cells were incubated at a concentration of 2 X 106/mL for 25 minutes at 37°C with an equal volume of 0.2% NBT dissolved in Dulbecco's PBS containing 200 ng of freshly diluted tetradecanoylphorbol acetate per milliliter. Reaction tubes were grossly examined for colored precipitate, and cytopreparations were made to assess the cellular content of blueblack formazan deposits.
Assessment of Proliferative Response to Cytokines
AML14.3D10 cells were cultured in complete medium for 72 hours with and without ATRA. After this, cells from both groups were placed in 96-well plates (1 X lo4 cells/well) in a total volume of 200 pL complete medium alone or with either recombinant human IL-5 (rhIL-5; a gift of Michael Grace, Schering Plough Corp. Kenilworth, NJ) or rhG-CSF (Genzyme, Cambridge, MA) in quadruplicate for 48 hours before the addition of 1 pCi [3H]-thymidine and culture for an additional 12 hours. Cells were then harvested onto glass fiber filters for liquid scintillation counting.
RESULTS
ATRA Treatment of AMLI4.3D10 Cells
Light microscopic study of AML14.3D10 cells cultured with ATRA showed striking changes over a 3-week period (Fig 1) . Within 24 hours, the cells had lost most of their eosinophilic granules as assessed by both Wright and fast green staining. This continued until 7 days, by which time no eosinophilic granules were visible and no fast green staining was detectable. Also during this time period, nuclear chromatin became more condensed and many cells developed nuclear indentations or segmentation and showed fine neutral-staining cytoplasmic granulation. The appearance of the cells at this stage strongly resembled that of maturing neutrophils. Although cell proliferation slowed during this period, it did not completely stop and there was no significant cell death in culture as assessed by serial inverted microscopic examination of cultures and assessment of viability by trypan blue staining. The cultures attained maximum morphologic maturity by day 10 to 14. After this, cell viability steadily declined until after day 21, when the cultures began to be repopulated by vigorously growing cells that now clearly evidenced eosinophilic differentiation by Wright and fast green staining. Identical results were obtained in eight separate experiments.
Assessment of Lineage-Spec@ Gene Expression
Analysis of mRNA expression of differentiation-related genes. AML14.3D10 cells show augmented expression of mRNA for the L -5 Ra subunit in comparison to parental AML14 cells or T F -1 cells. Treatment of AML14.3D10 cells with ATRA caused a rapid loss of detectable mRNA for the IL-5 R a subunit that was evident by 3 hours and complete by 48 hours. RNA remained undetectable for at least 10 days (Fig 2) . Uninduced AML14.3D10 cells did not contain detectable mFWA for the G-CSF receptor. After exposure to ATRA, G-CSF receptor mRNA was clearly evident by 5 days and appeared to be maximally expressed by days 7 to 10 (Fig 2) . receptor mRNAs was seen in three separate experiments. When proteins (MBP, EPO, CLC, and EDN) markedly decreased observed for longer intervals, G-CSF receptor mRNA became after treatment of AML14.3DIO cells with ATRA, but inundetectable after about 17 days, whereas L-5 a subunit creased again at 7 to IO days after treatment (Fig 3) . mRNA was again detected by 21 days (data not shown). (Fig 4) . Flow cytometric analysis of differentiation-related antigen expression. The CD16 antigen is expressed on neutrophils but not on eosinophils, a fact that has been found useful in purifying eosinophils by negative selection with CD16-coated magnetic beads." After ATRA treatment, CD16 became detectable on AML14.3D10 cells by 6 days and increased in intensity until 8 to 10 days (Fig 5) , after which expression decreased until it was no longer detectable by 17 to 21 days (data not shown). Over the time course studied, expression of CD33 remained essentially constant. These results were reproducible in four separate experiments. After ATRA-induced neutrophilic differentiation, mRNA for GM-CSF was not detected (Fig 6) .
Identical reciprocal modulation of L-5 Ra subunit and G-CSF
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Proliferative Response of AMLI4.3D10 to IL-5 or G-CSF
AML14.3D10 cells showed a proliferative response to IL-5, but no response to G-CSF (Fig 7A) . Seven days after exposure to ATRA, the cells no longer proliferated in response to IL-5, but now could be shown to be growth inhibited in response to G-CSF (Fig 7B) .
NBT Reduction
Little or no NBT was reduced by unstimulated AML14. 3D10 cells. However, cells that were treated with ATRA for 7 days rapidly reduced NBT. The reduced blue precipitate was easily visible in the reaction tubes (Fig 8) . Examination of cytopreparations showed formazan precipitates in the majority of ATRA stimulated cells, but not in cells that had not received ATRA.
DISCUSSION
These studies show that a clonal cell line that is committed to eosinophilic differentiation can change its differentiation program to the neutrophilic lineage after exposure to ATRA. A possible mechanism for this could be the induction of an alternative differentiation program in a small subpopulation of uncommitted stem cells present in phenotypically eosinophilic AML14.3D10 cultures. This is the mechanism that is apparently operative in other leukemic cell lines in which differentiation along multiple lineages can be i n d~c e d . '~.~~ The HL-60 cell line shows spontaneous differentiation to the promyelocyte stage and can be induced to neutrophilic, monocytic, eosinophilic, or basophilic lineages with a variety of agents.20.21 Sublines of HL-60 have been obtained that will differentiate predominantly to eosinophils when exposed to butyric acidZ2 or IL-5.23-25 These events show the induction of an immature myeloid precursor to a more differentiated phenotype.
In contrast to studies of the differentiation of HL-60 and other cell lines, our observations suggest that the lineage switch in our system occurs at least in part by a change in the differentiation program of cells that already show advanced evidence of eosinophilic differentiation. The addition of ATRA to AML14.3D10 cultures does not result in cell death.
Despite this, mRNA for the IL-5 Ra subunit is markedly diminished within hours and is undetectable by 48 hours. Serial light microscopic examination of cytopreparations of cultures after ATRA induction clearly shows a gradual loss of eosinophil-specific fast green staining in individual cells, with concomitant gradual acquisition of neutrophil morphology. During the first few days, mRNA for eosinophil granule proteins becomes undetectable, and granule protein levels also decrease, as reflected by measurement of MBP. By 5 days after ATRA, mRNA for the G-CSF receptor is detectable; by 6 days, CD16 is expressed. Modulation of cytokine receptor mRNA content is reflected in the biologic behavior of the cells, which are responsive to L-5 and unresponsive to G-CSF before ATRA induction, but are unresponsive to IL-5 and responsive to G-CSF after ATRA. Because cell death does not occur during the first 10 to 14 days after ATRA treatment, the fact that the cultures do not contain both phenotypically eosinophilic and neutrophilic cells during this interval strongly suggests that individual eosinophilic cells have suppressed the eosinophil differentiation program and activated the neutrophil program. We speculate that this phenomenon is observable in the AML14.3D10 cell line because of its apparent arrest at the eosinophilic myelocyte stage. Cells at this stage, although showing clear lineage commitment, are still capable of division and presumably still responsive to other influences regulating gene expression. After ATRA induction, cell death does occur after the peak expression of the neutrophilic phenotype at 10 to 14 days. This is likely due to a more complete or terminal differentiation along this lineage in response to ATRA. A small subpopulation of cells resistant to ATRA must exist in this system, because phenotypically eosinophilic cells invariably repopulate cultures after about 21 days. After this repopulation, it is possible to repeat the whole sequence of eosinophil to neutrophil transformation in the same culture by again adding ATRA.
It is possible that endogenous production of GM-CSF plays a role in the maintenance of proliferation and eosinophlic differentiation of the AML14.3D10 cell line. It is noteworthy that the phenotypically undifferentiated AML14 cell line,' from which AML14.3D10 was subcloned, does not produce GM-CSF (data not shown). After ATRA exposure, GM-CSF production is greatly reduced, suggesting the possibility that suppression of GM-CSF production could be permissive for the induction of the neutrophil differentiation program. Future experiments will address these issues.
The addition of ATRA to purified human hematopoietic progenitor cells cultured in the presence of IL-3 and GM-CSF has not been found to affect the eosinophilic differentiation induced by these cytokines2" However, ATRA has been shown to cause a decrease in erythroid differentiation and an increase in granulocytic differentiation in progenitor cultures supplemented with low doses of IL-3 and GM-CSF and saturating amounts of erythropoietin.*" These findings suggest a possible role for retinoids in the process of lineage commitment of normal progenitors.
Conventional models of hematopoiesis begin with multipotent stem cells that, in addition to self-renewal, either stochastically commit to a single lineage or produce progeny having progressively restricted lineage potential, resulting ultimately in progenitors that are capable of differentiation along only a single lineage.' In either model, once lineage commitment has occurred, the process has been thought to be irreversible. Although performed on an admittedly abnormal leukemic cell line, our studies suggest that lineage commitment may not be final. This concept is unconventional in regard to hematopoietic cells, but evidence has been obtained that differentiation shifts may occur in other tissues. Lung cancer cells, for example, have been shown to be switchable from neuroendocrine (small cell) to epithelial (adenocarcinoma)."
Cell differentiation is thought to be regulated largely at the level of gene transcription.2X There has been intense interest in recent years in the transcription factors that regulate expression of lineage-specific genes. Although a number of these have been described and functionally characterized in hematopoietic the hypothetical master switches that activate entire differentiation programs have remained elusive. Systems such as the one that we have described may provide valuable opportunities for the isolation of signals initiating or suppressing entire programs of differentiation.
